Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.
作者信息
Bossi Elisa, Aroldi Andrea, Brioschi Filippo A, Steidl Carolina, Baretta Silvia, Renso Rossella, Verga Luisa, Fontana Diletta, Sharma Geeta G, Mologni Luca, Mussolin Lara, Piazza Rocco, Gambacorti-Passerini Carlo
机构信息
Hematology Division, San Gerardo Hospital, Monza, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
出版信息
Am J Hematol. 2020 Dec;95(12):E319-E321. doi: 10.1002/ajh.25967. Epub 2020 Sep 3.
PMID:32808682
Abstract
摘要
Zotero 插件